Literature DB >> 23963052

Excretion of N(1), N(12)-diacetylspermine in the urine of healthy individuals.

Kyoko Hiramatsu1, Kouji Sakaguchi2, Nana Fujie3, Fumie Saitoh1, Emi Takahama1, Shun-suke Moriya1, Kaori Iwasaki1, Masayoshi Sakaguchi3, Kei-ichi Takahashi4, Masao Kawaikta5.   

Abstract

BACKGROUND: Urinary N(1),N(12)-diacetylspermine (DiAcSpm) is a novel tumour marker that can be used to detect early cancers. In this study, we examined whether spot urine samples could represent the daily excretion of DiAcSpm after creatinine normalization and which factors should be taken into account in determining reference values for this biomarker.
METHODS: We collected the following urine samples: (1) samples from seven healthy volunteers collected on each day of two 2-day sessions to examine the circadian variation of DiAcSpm excretion; (2) samples from 3952 male and 1782 female volunteers to estimate the DiAcSpm concentrations in apparently healthy adults and (3) samples from 16 female volunteers collected every morning over a 3-month period to examine the menstruation-related variation in DiAcSpm excretion. The DiAcSpm concentrations were determined by enzyme-linked immunosorbent assay or a colloidal gold aggregation procedure using DiAcSpm-specific antibodies.
RESULTS: (1) The circadian variation of DiAcSpm in the urine was greatly diminished after creatinine normalization. (2) DiAcSpm was higher in females than in males, and the creatinine-normalized medians (95th percentile) of the urinary DiAcSpm concentrations were 149 (305) and 100 (192) nmol/g creatinine for females and males, respectively. (3) The mean concentrations of urinary DiAcSpm were lower after menstruation than before menstruation by approximately 30 nmol/g creatinine.
CONCLUSION: Spot urine samples obtained at any time of a day may be used to estimate the daily excretion of DiAcSpm in nmol DiAcSpm per gram creatinine. Sex, age and menstrual condition should be considered when determining the reference values for urinary DiAcSpm.
© The Author(s) 2013 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.

Entities:  

Keywords:  Diacetylspermine; polyamine; reference value; tumour marker; urine

Mesh:

Substances:

Year:  2013        PMID: 23963052     DOI: 10.1177/0004563213496978

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  4 in total

1.  The importance of plasma arginine level and its downstream metabolites in diagnosing prostate cancer.

Authors:  Ismail Selvi; Halil Basar; Numan Baydilli; Koza Murat; Ozlem Kaymaz
Journal:  Int Urol Nephrol       Date:  2019-08-23       Impact factor: 2.370

2.  Significant correlation between urinary N(1), N(12)-diacetylspermine and tumor invasiveness in patients with clinical stage IA non-small cell lung cancer.

Authors:  Yusuke Takahashi; Hirotoshi Horio; Koji Sakaguchi; Kyoko Hiramatsu; Masao Kawakita
Journal:  BMC Cancer       Date:  2015-02-18       Impact factor: 4.430

3.  Pharmacometabolomics reveals urinary diacetylspermine as a biomarker of doxorubicin effectiveness in triple negative breast cancer.

Authors:  Thomas J Velenosi; Kristopher W Krausz; Keisuke Hamada; Tiffany H Dorsey; Stefan Ambs; Shogo Takahashi; Frank J Gonzalez
Journal:  NPJ Precis Oncol       Date:  2022-10-07

4.  Urinary N1, N12-diacetylspermine is a non-invasive marker for the diagnosis and prognosis of non-small-cell lung cancer.

Authors:  Yusuke Takahashi; Koji Sakaguchi; Hirotoshi Horio; Kyoko Hiramatsu; Shunsuke Moriya; Keiichi Takahashi; Masao Kawakita
Journal:  Br J Cancer       Date:  2015-10-27       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.